Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD44 antisense RNA 1 (ANKRD44-AS1)
- Target
- ANKRD44-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
ANKRD44 antisense RNA 1 (ANKRD44-AS1) is a human long non-coding RNA transcribed antisense to the ANKRD44 protein-coding gene on chromosome 2. It falls within the molecular class of lncRNAs and antisense RNAs. Current public genetic databases report association between ANKRD44-AS1 and conditions such as Covid-19, but no direct mechanistic studies, biological roles, or therapeutic targeting for this RNA are documented. Most published literature and disease mechanism data pertain to the protein-coding ANKRD44 gene rather than its antisense RNA. There are no known drugs, mechanisms, biomarker roles, or safety data related to ANKRD44-AS1.
- Other names
- ANKRD44-AS1ANKRD44 antisense RNA 1
02
Mechanism of action
not applicable. No drugs or interventions have reported mechanisms of action via this RNA.
03
Biological functions
Possible regulation of ANKRD44 gene expression (inferred from antisense location; no specific functional studies identified for the RNA)
04
Disease associations
Covid-19 (gene-disease association only; no mechanistic data)Other roles: Direct disease involvement not established; most data is on the protein-coding ANKRD44 and not the antisense RNA.
Beyond the preview
Go deeper on ANKRD44 antisense RNA 1 (ANKRD44-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ANKRD44 antisense RNA 1 (ANKRD44-AS1).